Klaus A Tiroch

Summary

Publications

  1. doi request reprint Pharmacological prevention and management of restenosis
    Klaus A Tiroch
    Deutsches Herzzentrum Munchen, Lazarettstrasse 36, D 80636 Munich, Germany
    Expert Opin Pharmacother 11:1855-72. 2010
  2. pmc Quantitative impact of cardiovascular risk factors and vascular closure devices on the femoral artery after repeat cardiac catheterization
    Klaus A Tiroch
    Department of Cardiovascular Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
    Am Heart J 159:125-30. 2010
  3. doi request reprint Risk predictors of retroperitoneal hemorrhage following percutaneous coronary intervention
    Klaus A Tiroch
    Brigham and Women s Hospital, Boston, MA, USA
    Am J Cardiol 102:1473-6. 2008
  4. doi request reprint Protective effect of the CYP2C19 *17 polymorphism with increased activation of clopidogrel on cardiovascular events
    Klaus A Tiroch
    Deutsches Herzzentrum Munchen, Rechts der Isar, Technische Universitat, Germany
    Am Heart J 160:506-12. 2010
  5. ncbi request reprint Heme oxygenase-1 gene promoter polymorphism and restenosis following coronary stenting
    Klaus Tiroch
    Deutsches Herzzentrum Munchen, 1 Medizinische Klinik rechts der Isar, Technische Universitat Munchen, Lazarettstrasse 36, München D 80636, Germany
    Eur Heart J 28:968-73. 2007
  6. ncbi request reprint Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting
    Werner Koch
    Deutsches Herzzentrum Munchen, Technische Universitat Munchen, Lazarettstrasse 36, D 80636 Munich, Germany
    Cytokine 24:161-71. 2003
  7. doi request reprint No association of chromosome 9p21.3 variation with clinical and angiographic outcomes after placement of drug-eluting stents
    Petra Hoppmann
    Deutsches Herzzentrum München and 1 Medizinische Klinik, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    JACC Cardiovasc Interv 2:1149-55. 2009
  8. doi request reprint Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction
    Gjin Ndrepepa
    Deutsches Herzzentrum, Technische Universitat, Munich, Germany
    Circ Cardiovasc Interv 3:27-33. 2010
  9. doi request reprint 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents
    Robert A Byrne
    Deutsches Herzzentrum, Technische Universitat, Munich, Germany
    J Am Coll Cardiol 55:2536-43. 2010
  10. ncbi request reprint Myocardial perfusion grade, myocardial salvage indices and long-term mortality in patients with acute myocardial infarction and full restoration of epicardial blood flow after primary percutaneous coronary intervention
    Gjin Ndrepepa
    Deutsches Herzzentrum, Technische Universitat, Munich, Germany
    Rev Esp Cardiol 63:770-8. 2010

Detail Information

Publications16

  1. doi request reprint Pharmacological prevention and management of restenosis
    Klaus A Tiroch
    Deutsches Herzzentrum Munchen, Lazarettstrasse 36, D 80636 Munich, Germany
    Expert Opin Pharmacother 11:1855-72. 2010
    ..Restenosis following intervention has been a key limitation of this therapy and, despite availability of a variety of therapeutic options, remains a challenging clinical entity...
  2. pmc Quantitative impact of cardiovascular risk factors and vascular closure devices on the femoral artery after repeat cardiac catheterization
    Klaus A Tiroch
    Department of Cardiovascular Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
    Am Heart J 159:125-30. 2010
    ..We evaluated the exact quantitative long-term impact of repeated catheterizations, vascular closure devices, and cardiovascular risk factors on the femoral artery after cardiac catheterization...
  3. doi request reprint Risk predictors of retroperitoneal hemorrhage following percutaneous coronary intervention
    Klaus A Tiroch
    Brigham and Women s Hospital, Boston, MA, USA
    Am J Cardiol 102:1473-6. 2008
    ..VCD use was not independently associated with the development of RPH (p = 0.74). In conclusion, this large prospective cohort study identified CRI, but not VCD use, as an independent predictor for RPH and peripheral vascular disease...
  4. doi request reprint Protective effect of the CYP2C19 *17 polymorphism with increased activation of clopidogrel on cardiovascular events
    Klaus A Tiroch
    Deutsches Herzzentrum Munchen, Rechts der Isar, Technische Universitat, Germany
    Am Heart J 160:506-12. 2010
    ..Reduced-function alleles have been associated with an increase in cardiovascular events...
  5. ncbi request reprint Heme oxygenase-1 gene promoter polymorphism and restenosis following coronary stenting
    Klaus Tiroch
    Deutsches Herzzentrum Munchen, 1 Medizinische Klinik rechts der Isar, Technische Universitat Munchen, Lazarettstrasse 36, München D 80636, Germany
    Eur Heart J 28:968-73. 2007
    ..We evaluated, whether an association existed between this polymorphism and the incidence of restenosis after coronary stenting...
  6. ncbi request reprint Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting
    Werner Koch
    Deutsches Herzzentrum Munchen, Technische Universitat Munchen, Lazarettstrasse 36, D 80636 Munich, Germany
    Cytokine 24:161-71. 2003
    ..In conclusion, functionally relevant polymorphisms of the genes for TNF-alpha, LT-alpha, and IL-10 do not represent genetic markers indicating the risk of restenosis, death, or MI after coronary stenting...
  7. doi request reprint No association of chromosome 9p21.3 variation with clinical and angiographic outcomes after placement of drug-eluting stents
    Petra Hoppmann
    Deutsches Herzzentrum München and 1 Medizinische Klinik, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    JACC Cardiovasc Interv 2:1149-55. 2009
    ..3 is a genetic factor for coronary heart disease, we investigated whether this locus influenced the clinical and angiographic outcomes after implantation of drug-eluting stents in coronary arteries...
  8. doi request reprint Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction
    Gjin Ndrepepa
    Deutsches Herzzentrum, Technische Universitat, Munich, Germany
    Circ Cardiovasc Interv 3:27-33. 2010
    ..We investigated the predictive factors, persistence in time, and impact of no reflow on myocardial salvage, ventricular function, and mortality...
  9. doi request reprint 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents
    Robert A Byrne
    Deutsches Herzzentrum, Technische Universitat, Munich, Germany
    J Am Coll Cardiol 55:2536-43. 2010
    ..The aim of the current study was to investigate the comparative clinical and angiographic effectiveness of SES, Dual-DES, and ZES between 1 and 2 years...
  10. ncbi request reprint Myocardial perfusion grade, myocardial salvage indices and long-term mortality in patients with acute myocardial infarction and full restoration of epicardial blood flow after primary percutaneous coronary intervention
    Gjin Ndrepepa
    Deutsches Herzzentrum, Technische Universitat, Munich, Germany
    Rev Esp Cardiol 63:770-8. 2010
    ....
  11. doi request reprint 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction
    Gjin Ndrepepa
    Deutsches Herzzentrum, Technische Universitat, Munich, Germany
    J Am Coll Cardiol 55:2383-9. 2010
    ..This impact was also assessed in relation to infarct size...
  12. doi request reprint Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study
    Julinda Mehilli
    Deutsches Herzzentrum, Technische Universitat, Munich, Germany
    J Am Coll Cardiol 55:2710-6. 2010
    ....
  13. doi request reprint Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials
    Alban Dibra
    Deutsches Herzzentrum, Technische Universitat, Lazarettstr 36, 80636, Munich, Germany
    Clin Res Cardiol 99:345-57. 2010
    ..Use of drug-eluting stents in patients with acute myocardial infarction (AMI) remains an "off label" indication due to concerns regarding their performance in this patient subset...
  14. doi request reprint A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation
    Jeffrey J Popma
    Beth Israel Deaconess Medical Center, Boston, MA, USA
    Am J Cardiol 103:923-9. 2009
    ..6%). In conclusion, stent fracture after Cypher stent placement occurs more often in patients with "ultra"-complex coronary anatomy, but is an uncommon event in patients treated with mild to moderate lesion complexity...
  15. doi request reprint High-frequency vibration for the recanalization of guidewire refractory chronic total coronary occlusions
    Klaus Tiroch
    Cardiovascular Division, Department of Internal Medicine, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Catheter Cardiovasc Interv 72:771-80. 2008
    ..Recanalization of coronary chronic total occlusions (CTOs) remains a clinical challenge, particularly when standard guidewire attempts fail...
  16. doi request reprint Peak cardiac troponin-T level, scintigraphic myocardial infarct size and one-year prognosis in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction
    Robert A Byrne
    Deutsches Herzzentrum, Technische Universitat, Munich, Germany
    Am J Cardiol 106:1212-7. 2010
    ..Compared to peak CK-MB, peak TnT shows similar correlation with scintigraphic infarct size, although scintigraphic infarct size remains a better correlate of 1-year mortality than either biomarker...